Abstract: Microbubbles as traditional ultrasound contrast agents have seen tremendous developments and bio-applications in the past decades. Due to their outstanding performance, advanced microbubbles as a multifunctional platform combining both imaging and therapy have been increasingly attracting attention. Associated with ultrasound-mediated stimuli, targeting drug transportation with high precision can be established and, as a consequence, a synergistic treatment strategy may prevail, which implies a bright perspective for this brand-new technology. This perspective article will summarize the latest developments on the advanced microbubbles, and review their emerging biomedical applications for the vast community of both applied ultrasound and functional ultrasound-based materials.
Introduction
Ultrasound (US) is widely used in clinics and has become a traditional diagnostic strategy for various diseases due to outstanding profiles such as low cost, ionization-free radiation, real-time availability, portable operation, etc. [1] . US imaging has been applied in vast fields from abdomen or superficial lesions to heart and intracavitary examinations. In order to enhance the image contrast and resolution, ultrasound contrast agents (UCAs) are always used in clinical diagnosis. Gramiak and Shah first reported UCAs in echocardiography in 1968 [2] . The saline injection was administered in heart which dramatically improved the quality of ultrasonography due to the bubbles in the contrast medium. In this sense, contrast-enhanced ultrasonography (CEUS) has been investigated in the last decades and has become a routine method to diagnose diseases with comparable contrast enhancement with computed tomography (CT) or magnetic resonance imaging (MRI) [3] . Thus, US exhibits great potential as a powerful diagnostic tool to detect pathological behavior with prominent precision and efficiency.
Moreover, UCAs have been applied not only for diagnosis but also for therapy such as thrombolysis and drug delivery. UCAs such as microbubbles have proved effective in curing intravascular thrombus [4] . Kaneko et al. disclosed that high-intensity focused ultrasound associated with UCAs could be used in the liver treatment [5] . The microbubbles could be destroyed by ultrasound, and the permeability of cell membranes could be increased, enabling them to perform drug/gene delivery [6, 7] . Therefore, UCAs present a great opportunity not only as a powerful diagnostic tool but also as a multifunctional platform to serve therapeutic purposes in clinics. Further perspectives by using microbubbles (MBs) as UCAs and drug/gene delivery carriers will imply emerging developments versatile platform. At present, several kinds of commercial UCAs have been approved in clinical applications (Table 1) .
Levovist and Albunex can be used in cardiovascular imaging; however, because of their disadvantages of bad enhancement effect and short duration, Levovist and Albunex gradually exited the contrast media market around 2000. SonoVue is mainly used to characterize liver lesions. The use of SonoVue to assess the early response to anti-angiogenetic drugs in cancer chemotherapy has been studied. With promising results, wider studies are ongoing. Optison was much more effective at killing cells than other agents, and may be the best US microbubble contrast agent for gene therapy [8] . The UCAs whose gas core contain C3F8 are considered the best material for microvascular imaging. Over the past few years, ultrasound molecular imaging (UMI) and ultrasound molecular therapy (UMT) have made leaps toward everlasting developments in both preclinical and clinical investigations to detect the disease processes at the molecular or cellular level in a visualizable manner. With the introduction of novel specific biomarker-targeted UCAs, early-stage detection and therapy will be achieved. At present, these studies mainly focus on the fields of tumor detection, inflammation, cardiovascular diseases, blood-brain barrier (BBB) disruption, brain metastasis, thrombolysis and related interdisciplinary sections (Figure 1 ). 
Advanced Microbubbles for Imaging and Therapy

Tumor Detection
Although MBs can improve ultrasound image resolution, there is no specific targeting capability for them to differentiate between normal and cancerous tissues. Thus, MBs are always constructed with the attachment to specific binding ligands such as peptides, affibodies, antibodies, etc. to be able to actively target the tumor areas. With the targeted MBs anchoring at the cancerous regions, ultrasonic echo signals can be significantly enhanced which leads to early diagnosis of cancers. In the process of tumor angiogenesis, the integrin family is a main factor of mediating cell and extracellular matrix adhesion. The relationship between integrin αvβ3 and tumor angiogenesis is the most attractive to researchers and has become a hot topic. Integrin αvβ3 receptor is overexpressed on the surface of a variety of malignant tumors and endothelial cells of tumor tissue angiogenesis, otherwise not expressed in mature vascular endothelial cells and the vast majority of normal organ systems. Its overexpression provides molecular targets as imaging probes and could be used in ultrasound to detect angiogenesis. Yan developed iRGD (internalizing arginine-glycine-aspartate)-lipopeptide-based αvβ3 integrin-targeted MBs (1.36 ± 0.89, 1.24 ± 0.74, 1.09 ± 0.61 µm) as non-invasive molecular imaging probes to tumor angiogenesis [33] . The binding specificity for endothelial cells was significantly stronger (p < 0.01) under in vitro static and dynamic conditions. US images revealed strong contrast enhancement within the mice bearing 4T1 breast tumors compared with the control MBs. In addition to integrins, vascular endothelial growth factor receptors (VEGFRs) are regarded as another kind of specific biomarker of neoangiogenesis. Nascimento designed VEGFR2-targeted MBs in combination with 40 MHz endoluminal ultrasound biomicroscopy (eUBM) to detect colon tumors [34] . Wei developed VEGFR2-targeted MBs in an orthotopic model of renal cell carcinoma (RCC) to image angiogenesis. Compared with MBs conjugated to an isotype control antibody (MBC) or naked microbubbles (MBN), the duration of contrast enhancement of MBs conjugated to anti-VEGFR2 antibody (MBV) demonstrated prolonged contrast intensity within the tumor. Furthermore, the contrast intensity for MBV was significantly higher in the tumors than in normal parenchyma (p < 0.01) [35] . Pillai purified phospholipid-PEG2000-peptide which has nanomolar affinity for VEGFR2, and incorporated it into gas-filled microbubbles. In vivo experiments showed the VEGFR2-targeted microbubbles (BR55) greatly provided imaging of angiogenesis [36] (Figure 2 ). In a further study, Sorace established triple-targeted MBs with antibodies against mouse αvβ3 integrin, P-selectin and VEGFR2 for evaluating the early response to antiangiogenic therapy. Tumor-bearing mice were injected with the multi-targeted microbubbles for contrast-enhanced US imaging and microbubble accumulation was calculated by destruction-replenishment techniques and time-intensity curve analysis. It was found that the vascularity of breast cancer decreased within Day 1 of bevacizumab injection by real-time monitoring of molecular US imaging, and further reduction of vascularity was detected by day 3 [37] . Bachawal found that vascular expression of B7H3 was selectively and significantly higher in breast cancer tissues through an IHC analysis of 248 human breast specimens. Then a kind of B7H3-targeted MB was prepared to identify that the US imaging signal increased significantly in breast cancer tissues in vivo. These findings concluded that the use of B7H3-targeted MBs can be a useful tool to improve the diagnostic accuracy of breast cancer detection in patients [38] . US imaging can also be applied to monitor the tumor angiogenesis during tumor development [39] . Hu et al. conjugated RGD peptides to the MB shell via biotin-avidin linkage. These RGD-MBs showed significantly higher adhesion to ανβ3-expressing endothelial cells compared to the controls. In vivo experiments verified that the quantitative acoustic intensity in Hep2-tumor xenografts showed significantly higher in small tumors (19.89 ± 2.49) than those in medium (11.25 ± 2.23) and large tumors (3.38 ± 0.67).The results concluded that RGD-MBs enabled non-invasive in vivo visualization of tumor angiogenesis during tumor growth in Hep2 cancers [40] . In addition to the targeted microbubbles have showed above to assess the tumor angiogenesis, the other targeted UCAs applied in animal experiments have been summarized in Table 2 . Microsized bubbles can only be used for intravascular imaging, but nano-scaled bubbles can be carried out of vasculature for tumor tissue imaging. Mai prepared biocompatible chitosan-VC lipid nanobubbles (NBs) to conjugate Cy5.5 as ultrasound-fluorescence dual-modal contrast agents for tumor imaging in mouse tumor model injected with murine liver cancer cells H22. Their sizes range between 400 and 800 nm, and both in vitro and in vivo studies indicated that they had high accumulation in tumors [41] . Kim et al. prepared CaCO3 nanoparticles as ultrasound enhancedcontrast agents (UECAs) for tumor ultrasound imaging. In vivo experiment showed this nanosized UECA had a significant US contrast enhancement at the tumor site and was excreted out quickly [42] ( Figure 3 ). Yang fabricated NBs (478.2 ± 29.7 nm in diameter, PDI 0.164 ± 0.044) via a thin-film hydration method, and successfully attached the NBs with biotinylated anti-ErbB2 affibody, which has high affinity and specificity for the HER2 overexpressed in some breast cancer tumors [43] . It was found that these NB-affibody conjugates were promising candidates for HER2-positive tumors and applicable for quantitative diagnosis. A novel kind of nanoparticle containing folate-PEG-chitosan and perfluorooctyl bromide cores was prepared [44] . Not only excellent stability and biocompatibility Microsized bubbles can only be used for intravascular imaging, but nano-scaled bubbles can be carried out of vasculature for tumor tissue imaging. Mai prepared biocompatible chitosan-VC lipid nanobubbles (NBs) to conjugate Cy5.5 as ultrasound-fluorescence dual-modal contrast agents for tumor imaging in mouse tumor model injected with murine liver cancer cells H22. Their sizes range between 400 and 800 nm, and both in vitro and in vivo studies indicated that they had high accumulation in tumors [41] . Kim et al. prepared CaCO 3 nanoparticles as ultrasound enhanced-contrast agents (UECAs) for tumor ultrasound imaging. In vivo experiment showed this nanosized UECA had a significant US contrast enhancement at the tumor site and was excreted out quickly [42] (Figure 3 ). Yang fabricated NBs (478.2 ± 29.7 nm in diameter, PDI 0.164 ± 0.044) via a thin-film hydration method, and successfully attached the NBs with biotinylated anti-ErbB2 affibody, which has high affinity and specificity for the HER2 overexpressed in some breast cancer tumors [43] . It was found that these NB-affibody conjugates were promising candidates for HER2-positive tumors and applicable for quantitative diagnosis. A novel kind of nanoparticle containing folate-PEG-chitosan and perfluorooctyl bromide cores was prepared [44] . Not only excellent stability and biocompatibility were confirmed, but also an increased amount of targeted nanoparticles was observed accumulated in hepatocellular carcinoma cells.
were confirmed, but also an increased amount of targeted nanoparticles was observed accumulated in hepatocellular carcinoma cells. 
Inflammation
The pathophysiology of inflammation is a series of molecular signals generated by the inflammatory responses that turn the leukocytes into the inflamed tissues. Leukocytes firmly adhere to the vascular endothelial cell wall before they transmigrate from the blood circulation into inflamed tissues. P-selectin expresses rapidly on activated endothelial cells upon inflammation occurs. The endothelial cells also overexpress E-selectin, and leucocytes can overexpress L-selectin, intercellular adhesion molecule1 (ICAM-1) and vascular cell adhesion molecule1 (VCAM-1) which can mediate the adhesion of leucocytes and endothelial cells at the inflammatory lesions. Therefore, P-, E-and Lselectin, ICAM-1 and VCAM-1 can be used as specific biomarkers of inflammation to evaluate their occurrence at an early stage. Molecular US imaging has been successfully applied to inflammations including inflammatory bowel diseases, myocardial ischemia, arthrosclerosis, and rejection in cardiac transplantation. Bettinger developed P-selectin glycoprotein-functionalized MBs (MBrPSGL-Ig) [60] . 
The pathophysiology of inflammation is a series of molecular signals generated by the inflammatory responses that turn the leukocytes into the inflamed tissues. Leukocytes firmly adhere to the vascular endothelial cell wall before they transmigrate from the blood circulation into inflamed tissues. P-selectin expresses rapidly on activated endothelial cells upon inflammation occurs. The endothelial cells also overexpress E-selectin, and leucocytes can overexpress L-selectin, intercellular adhesion molecule1 (ICAM-1) and vascular cell adhesion molecule1 (VCAM-1) which can mediate the adhesion of leucocytes and endothelial cells at the inflammatory lesions. Therefore, P-, E-and L-selectin, ICAM-1 and VCAM-1 can be used as specific biomarkers of inflammation to evaluate their occurrence at an early stage. Molecular US imaging has been successfully applied to inflammations including inflammatory bowel diseases, myocardial ischemia, arthrosclerosis, and rejection in cardiac transplantation. Bettinger developed P-selectin glycoprotein-functionalized MBs (MBrPSGL-Ig) [60] . The adhesion efficiency of MBrPSGL-Ig constructs under static or flow conditions and molecular imaging studies were performed in the rat inflammatory model by intravenous injection of MBs with monitoring the accumulation of targeted MBs in the muscle. It proved that they could interact specifically and efficiently with E-and P-selectin at the surface of inflamed endothelial cells. The echo signals measured with MBrPSGL-Ig in the inflamed muscles was 20-fold higher compared with control MBs. The in vivo adhesion of MBrPSGL-Ig was 2-and 7-fold higher compared with P-selectin or E-selectin-specific MBs, respectively. Wang developed dual-targeted MBs (MBSelectin) for P-and E-selectin-specific inflammation in a murine acute colitis model [61] . Small animal imaging experiments showed that MB-selectin had strong attachment to both human and mouse P-and E-selectin and significantly increased US signals in mice. They concluded with US imaging inflammation in a murine acute colitis model could be quantitatively detected and the natural pathway of leukocyte recruitment in inflammatory tissues has been revealed. Machtaler et al. assessed acute inflammation with dual P-and E-selectin-targeted US imaging [62] . Mice at different stages of inflammation were imaged following intravenous injection of P-and E-selectin-targeted MBs. It showed the US signals increased due to induction of acute inflammation at days 0, 1, and 3, and the percentage of P-and E-selectin-positive vessels increased in immunofluorescence. This method has been consolidated to accurately measure acute inflammation in a clinically relevant murine model of chronic IBD.
The molecular US imaging also can monitor the early inflammatory effects following acute kidney injury with P-selectin-targeted and VCAM-1-targeted MBs, which has been developed by Hoyt et al. [63] . Non-invasive imaging for detecting acute cardiac transplant rejection was considered impossible in the past. Weller conjugated anti-rat ICAM-1 to lipid-based MBs (MBICAM) to detect acute rejection of cardiac transplantation. MBICAM was found to adhere to inflammatory endothelial cells in vitro and in vivo; moreover, myocardial video intensity from adhered MBICAM was found significantly higher, thereby implying that ICAM-1-targeted MBs may offer a non-invasive US imaging methodology for the successful detection of acute cardiac transplant rejection [64] .
Cardiovascular Diseases
It is difficult to diagnose the thrombus in the blood vessels or heart cavity since in some cases a small thrombus is hard to locate. In recent years, a variety of thrombus-targeted MBs have been engineered to provide a new perspective for emboli detection by means of US imaging. Hagisawa developed the perfluorocarbon-containing bubble liposomes (BL) with RGD peptides, which bind to activate platelet glycoprotein IIb/IIIa complexes to enhance signals in thrombus US imaging [65] . The targeted BL were mixed with whole blood in vitro, and injected into rabbits with acute thrombotic occlusions in the ilio-femoral artery in in vivo experiments and used a 7.5-9 MHz linear transducer and a conventional ultrasound machine to image the thrombi. The results showed that these targeted MBs could markedly enhance the image contrast in thrombus imaging and may be useful for diagnosing acute thrombotic vessel occlusion. Ultrasound of arterial thrombi has immense potential, but the high-shear arterial flow limited effective binding of MBs to the thrombi. To overcome this obstacle, cyclic peptide with a sequence of Arg-Gly-Asp-D-Phe-Cys was fabricated and proved that they had much higher binding affinity and selectivity to the glycoprotein IIb/IIIa receptors than its linear counterparts. They are thus likely to be the optimal targeted probes for imaging arterial thrombi with US modality. Hu also constructed novel MBs conjugated to detect arterial thrombi, which had greater GP IIb/IIIa-targeted binding capability under all shear stress conditions [66] . The echogenicity of the platelet-rich thrombus was enhanced in vitro and the intensity of the abdominal aortic thrombi showed 3.2-fold higher than the control in vivo. With this technique, ultrasound provides a strategy to diagnose the acute coronary syndrome in patients without clear symptoms or electrocardiographic features. Hyvelin applied clinically translationable dual P-and E-selectin-targeted MBs to detect transient myocardial ischemia [67] . The results showed high US imaging enhancement within the ischemic area compared with remote myocardial tissues in myocardial ischemia/reperfusion rats. In the meantime, it has been demonstrated that these dual selectin-targeted MBs in transient myocardial ischemia provide reliable detection of transient myocardial ischemic events (late-phase enhancement persisted 5 and 24 h post reperfusion) without inducing ventricle dysfunction and myocardial necrosis.
Blood-Brain Barrier Disruption
The blood-brain barrier (BBB) is a special capillary endothelial system with tight junctions and metabolic barriers. It can keep the internal central nervous system (CNS) stabilized by preventing the macromolecular agents from transportating freely, but can also hinder neuro-active substances and drugs (such as nervous peptides, proteins and chemotherapeutic drugs) from curing brain diseases by BBB opening. Since 2001, Hynynen et al. found that the intravenous injection of MBs before focused ultrasound (FUS) irradiation can significantly enhance the opening of BBB, and the BBB could remain intact within 24 h without causing any neuronal injuries [68] . Therefore, the study of focused ultrasound on opening BBB as a novel therapeutic method associated with functional MBs has implied a new era in this regard [69] (Figure 4 ). Mooney determined that transcranial FUS techniques could be used to transiently open the BBB and stimulate hippocampal neurogenesis [70] . They also found that FUS at a pressure of~0.78 MPa along with MBs could promote hippocampal neurogenesis and efficiently increase the BBB permeability. 
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Fan proposed the use of folate-conjugated DNA-loaded cationic MBs (FCMBs) to increase the efficiency of gene delivery to brain tumors and optimized the FUS parameters for FCMB-enhanced gene delivery by cell experiments. It indicated that FCMBs show better gene transfection efficiency than MBs without folate conjugation [73] .
Numerous experiments have confirmed that the BBB disruption has an expansibility significance in the CNS. Samiotaki found that the use of FUS combined with MBs can promote the nerve growth factor into the substantia nigra striatum with peripheral intravenous administration [74] . At 1 h after administration, the biological activity of the nerve growth factor in the substantia nigra striatum was significantly higher than the direct administration without FUS, and the activation of the downstream signal pathway of nerve growth factor was detected in the neurons. Lin further developed a new delivery protocol by conjugating gene-loaded liposomes with MBs. They successfully improved gene-delivery efficiency and applied it to Parkinson's disease (PD) treatment. This study demonstrated that the gene-loaded MBs with FUS-induced BBB opening was an effective approach and might be a therapeutic strategy for neurodegenerative diseases such as Parkinson's, Alzheimer's and Huntington's diseases [75] . Leinenga applied repeated scanning ultrasound (SUS) for treatments of the mouse brain to remove Ab which is implicated in the pathogenesis of Alzheimer's disease [76] . Their findings suggest that repeated SUS treatment could induce microglia to effectively cleanse Ab and may be potentially promising for Alzheimer's therapy. Aryal et al. further tested the impact of periodic FUS in combination with liposomal doxorubicin (DOX) in a rat glioma tumor [77] . They found a pronounced improvement in median survival time by 100% of rats that received FUS + DOX compared to rats only treated with DOX or FUS, and approximately 75% of tumors appeared almost completely cured in the FUS + DOX group. Multiple sessions using FUS to enhance the delivery of liposomal doxorubicin had a prominent effect in a rat glioma model.
The study on BBB opening is not confined to animal experiments, but has been translated to clinical trials to some extent. A first clinical test on US-assisted chemotherapy for malignant brain tumors has been carried out at the University of Toronto in 2015 [78] . Carpentier et al. also applied Sonocloud as an US device for treatment with carboplatinin patients with recurrent glioblastoma (GBM) in a clinical trial. The BBB opening using Sonocloud combined with monthly systemic microbubble injection proved to be safe and well tolerated in patients, and acceptable treatments have been effective according to current clinical data [79] .
Thrombolysis
Thrombotic arterial occlusion is the major cause of acute cardiovascular syndromes such as stroke and myocardial infarction. Exposing the thrombus to MBs in the presence of US mediation can facilitate the thrombus disruption, and thus become a powerful methodology for thromboembolic diseases. Multiple studies have confirmed that US is capable of accelerating thrombolysis. In the 1970s, Trubestein first suggested applying US to destroy thrombi. Artificial human blood clots were exposed to 170 kHz of US and urokinase, and albumin MBs were introduced to trigger the acceleration of thrombolysis. Follow-up studies were focused on the evaluation of the thrombolytic efficacy between desmoteplase (DSPA) combining with therapeutic US and rt-PA treatment. The results showed that DSPA combined with 2-MHz US significantly accelerated rt-PA lysis (32.8% vs. 26.5%) [80] [81] [82] . Schleicher determined the effect of BR38 and Sonovue on MB-enhanced sonothrombolysis in a rat stroke model and concluded that it may be a therapeutic strategy for patients with continuous hypoperfusion of the ischemic territory [83] . Petit also investigated the impact of MB-mediated sonothrombolysis on the fibrin network of clots [84] . They showed that the combination rt-PA + US + MB enhanced both the diameter loss (0.77 ± 0.07 mm) and fibrin degradation (50.3% ± 2.4%) compared to rt-PA alone (0.24 ± 0.01 mm and 36.5% ± 1.7%), which implied a strong synergistic effect. It was also found that sonothrombolysis with MB greatly improves rt-PA-mediated clot lysis and fibrin degradation. On this basis, Lu injected platelet-or erythrocyte-rich microthrombi in intracarotid artery to induce the acute ischemic stroke rat model. In comparison, the effect of US + MB + rt-PA groups was the highest in cerebral infarction reduction and neurological deficits improvement. All these studies confirmed that MB-mediated sonothrombolysis has high effectiveness and good outcome in microemboli-induced acute ischemic strokes through dissolution of the microthrombi [85] .
Rapid dissolution and reduction of thrombus is the principal goal for patients with intermediate-and high-risk pulmonary embolism (PE). By analysis with 53 consecutive patients with intermediate-risk PE treated with US-assisted catheter-directed thrombolysis at Brigham and Women's Hospital from 2010 to 2014, there was a reduction of 7.2 and 11.4 mmHg in mean and systolic pulmonary artery pressure after treatments [86] .
Drug/Gene Delivery
The technology of ultrasound-targeted microbubble destruction (UTMD) has become one of the most promising strategies for the targeted delivery of drugs/genes, which can protect the drugs/genes from capture or destruction by the external environment, and achieve US-triggered targeted drug/gene delivery to the lesions. Studies show that the efficiency of UTMD is mainly determined by the pressure, duration of US exposure and MB concentration [87] . Zhao et al. used the heparinized MBs carrying acidic fibroblast growth factor (aFGF) in combination with UTMD to study rat models with myocardial infarction, and found that the technique of UTMD could effectively facilitate aFGF delivery to the myocardium and therefore improve cardiac function recovery [88] . Fuji injected stem cell factor (SCF) and stromal cell-derived factor (SDF-1α) into rats with myocardial infarction with the assistance of UTMD. The results showed that the delivery of SCF and SDF-1α to the infarcted myocardium recruited progenitor cells after treatments, and led to increased vascular density and enhanced tissue repair [89] . Liao et al. disclosed US-MB-mediated diclofenac delivery to treat adjuvant-induced rheumatoid arthritis (RA) in rats. By combining US and MBs, the skin permeability could be increased which thereby enhanced the delivery of diclofenac sodium gel and also inhibited inflammation of the tissues surrounding the arthritic ankle. Color Doppler-mode US imaging revealed that US-MB combinatory treatments induced a rapid reduction in synovial neoangiogenesis in the arthritic area [90] . Xiang et al. further optimized the UTMD technique by improving the in vivo transfection efficiency of the enhanced green fluorescent protein (EGFP) plasmid in the synovial pannus in an antigen-induced arthritis rabbit model. The EGFP expression in the synovial pannus of the US + MBs + plasmid group was significantly higher than that of the other four groups. This validated that UTMD has become a safe and effective non-viral gene transfection procedure for arthritis therapy [91] . Zhang's group developed simvastatin (Sim)-loaded polymeric MBs for targeting inflamed vascular endothelium to serve the diagnosis and treatment of atherosclerosis. This gas-filled MBs for drug delivery demonstrated promises to provide a stable acoustic enhancement and effectively identify atherosclerotic areas of plaque within the ventral aorta of rabbits [92] . Chertok modified the surface of DNA nanocarriers with heparin to inhibit passive gene transfer in both the target and the off-target tissues, and selectively activated heparin-inhibited gene to transfer at the target site by using UTMD [93] . They observed that the engraftment reduced off-target gene expression in the liver by more than 700-fold compared to the non-heparinized PEGylated liposomes; tumor-directed UTMD increased gene transfer with heparin-modified nanoplexes by more than 10-fold ( Figure 5 ). Not only can UTMD increase the delivery of drugs/genes, but the ultrasound itself can also improve the efficiency of delivery. In a study, Chung designed a novel 68 Ga-labeled integrin α2β1-targeted PET tracer 68 Ga-NOTA-PEG4-cyclo (GDGEAyK) ( 68 Ga-A2B1) and uptake was higher in subcutaneous U87MG tumor-bearing athymic mice [94] . Then they found that with or without tracer integration of microbubbles, 68 Ga-A2B1 tumor uptake could be improved in combination with focus ultrasound (Figure 6 ). The UTMD technology does not only increase the localized drug concentration at the targeted organs or tissues, but it also reduces the side effects of systemic drugs. This has been proved by Chen Not only can UTMD increase the delivery of drugs/genes, but the ultrasound itself can also improve the efficiency of delivery. In a study, Chung designed a novel 68 Ga-labeled integrin α2β1-targeted PET tracer 68 Ga-NOTA-PEG4-cyclo (GDGEAyK) ( 68 Ga-A2B1) and uptake was higher in subcutaneous U87MG tumor-bearing athymic mice [94] . Then they found that with or without tracer integration of microbubbles, 68 Ga-A2B1 tumor uptake could be improved in combination with focus ultrasound (Figure 6 ). Not only can UTMD increase the delivery of drugs/genes, but the ultrasound itself can also improve the efficiency of delivery. In a study, Chung designed a novel 68 Ga-labeled integrin α2β1-targeted PET tracer 68 Ga-NOTA-PEG4-cyclo (GDGEAyK) ( 68 Ga-A2B1) and uptake was higher in subcutaneous U87MG tumor-bearing athymic mice [94] . Then they found that with or without tracer integration of microbubbles, 68 Ga-A2B1 tumor uptake could be improved in combination with focus ultrasound (Figure 6 ). The UTMD technology does not only increase the localized drug concentration at the targeted organs or tissues, but it also reduces the side effects of systemic drugs. This has been proved by Chen The UTMD technology does not only increase the localized drug concentration at the targeted organs or tissues, but it also reduces the side effects of systemic drugs. This has been proved by Chen et al. who prepared hydrogen sulfide-loaded MBs (hs-MBs) with different H2S/C3F8 ratios, and US-targeted hs-MB destruction was applied in a rodent model of myocardial ischemia-reperfusion injury. The optimal ratio of H2S/C3F8 was found to be 2/2 with the highest H2S-loading capacity. US-targeted hs-MB destruction controlled myocardial infarct sizes and also preserved left ventricular functions without any influence on hemodynamics or the respiratory system, thus leading to myocardial ischemia-reperfusion injury alleviation [95] . Zhu et al. tested the injection of DOX in the H22 hepatocellular carcinoma (HCC)-xenografted models combined with UTMD. Animals treated with DOX + UTMD combination had the highest tumor inhibition rate and survival rate among all tumor-burden groups (p < 0.001). The combination therapy of DOX + UTMD indicated improved antitumor effects for HCC and reduced the systemic side effects significantly [96] .
Stem Cell Transplantation
Although stem cell transplantation has been applied in treatments of various diseases, its clinical application is restricted by the influence of survival rate and targeting of stem cells. To this end, US + MBs cannot only mediate the gene transfection, but also facilitate targeted delivery of transplanted cells to improve the performance of stem cell transplantation. Zhong transplanted DAPI-labeled MSCs to the myocardial infarction models by means of UTMD, and found that the expression of various cytokines in UTMD-treated animals was much higher than that observed in non-treated controls. They concluded that UTMD changes the myocardial microenvironment and promotes the homing of MSCs to the ischemic myocardium [97] . Xu established the targeted delivery of MSCs into the myocardium by using diagnostic US irradiating lipid-coated MB destruction along with bone-marrow-derived MSC infusion. The cardiac function was markedly improved and the number of capillaries was increased, whereas, the area of cardiac fibrosis was significantly decreased with US + Microbubble + MSC treatment [98] . Pu and his fellows transferred pcDNA3.1-hVEGF165 into MSCs by UTMD, and observed the effect of the protein expression. It showed that the VEGF165 protein expression increased at 24 h and reached the maximum level at 48 h. Compared with the control, protein expression of the UTMD group was significantly increased. It also found that VEGF165 protein level varied to different UTMD conditions. A significant protein expression was yielded by UTMD-mediated transfection of MSCs with a mechanic index of 0.6 for 90 s [99] .
Bone marrow stromal cell (BMSC) transplantation proves successful in treating kidney diseases. Wang et al. applied UTMD to enhance CXCR-4 transfection efficiency to improve BMSC homing to AKI kidneys, which showed the migration ability of CXCR4-modified BMSCs was 9-fold higher than controls without UTMD [100] . Wu developed SDF-1-loaded MBs (MBSDF-1) via covalent conjugation to improve MSC homing to diabetic nephropathy (DN) kidneys. SDF-1 was successfully released in the targeted kidneys in the in vivo study. The homing efficacy of MSCs to DN kidneys after the targeted release of SDF-1 was remarkably ameliorated at 24 h [101] . Zhang also performed UTMD to increase the renoprotective effect of kidney-targeted transplantation of bone-marrow-derived mesenchymal stem cells (BM-MSCs) in DN rats. MSCs were injected in combination with UTMD to DN rats at four weeks after diabetes onset. The results demonstrated MSC transplantation could decrease blood glucose concentrations and attenuate pancreatic islets/β cells damage. The permeability of renal interstitial capillaries and VCAM-1 expression increased after UTMD employment, which enhanced homing and retention of MSCs to kidneys. MSC transplantation associated with UTMD prevented renal damages and decreased albumin excretion rate (AER) values. It was concluded that UTMD non-invasively increased the homing of MSCs to kidneys and promoted renal repair in DN rats [102] .
Challenges and Perspectives
Ultrasound (US) imaging is one of the most widely used medical imaging modalities in clinics, due to its advantages of non-invasiveness, ionization-free radiation, real-time availability and commercially low costs. These unique advantages and apparent potential of ultrasound differentiates it from other techniques. The introduction of multifunctional microbubbles (MBs) rejuvenates resolution with improved sensitivity and specificity. By conjugating specific ligands to the MBs to construct targeted "missiles," these MBs can be oriented to the diseased lesions with unprecedented precision. Moreover, this targeted therapy can be enhanced by carrying drugs/genes on the engineered MBs so that a combinatory strategy with both synergistic chemo-physical treatments can be implemented.
However, the development of multifunctional MBs and the MBs + US technique are still in its infancy, and several bottleneck issues exist. For example, it is mostly used in intravascular diseases due to the micron sizes, but it is difficult to realize the investigation of a single cell or isolated tissues. Presently, nano-scaled bubbles are not well studied, and it is difficult to meet the actual requirements in this respect. Secondly, multiple targeting may offer better diagnosis than single or dual targeting. Nevertheless, it is still challenging to fabricate multifunctional MBs with better stability and prolonged circulation profiles. The limitation of real practical use of MBs in the work of Lamanauskas et al. was that sonoporation efficiency is relatively low [24] . Liu et al. analyzed 26 recent published papers and found that only a small part of the data illustrated sonoporation efficiency beyond 50% [103] . Another common limitation was the small number of samples; more detailed studies are thus needed in future research [104] .
In addition, safety evaluation is always an issue regarding the successful translation of the multifunctional MBs to humans. Future focus could emphasize the improvement of their biocompatibility and biodegradability. Potential toxicity and side effects for clinics should also be taken into consideration. In addition, secondary risks induced by US technology such as microcirculation vascular damage effect, ecchymosis and hypotension are also worthy of systematic investigations.
Although there are still a lot of areas in need of improvement, contrast agents, such as SonoVue, have been approved for human use by the FDA and are widely used for clinical examinations in China. Compared to other US, SonoVue reflects its safety in myocardial perfusion assessment, abdominal applications and transcranial ultrasound diagnostics [105] [106] [107] . The four-dimensional hysterosalpingo contrast sonography, combined with SonoVue, achieves a real-time, intuitive examination [108] . Additionally, SonoVue has recently been used to expand the yield of gene delivery. US-mediated gene delivery combined with MBs was evidenced to be significantly safer than other local gene-delivery methods [109] . The combination of US-mediated MB destruction and shRNA could enhance antitumor efficacy [110] . One study conducted by Zheng also found that SonoVue enhanced the efficiency of rAAV transfection to RPE-J cells [111] .
In conclusion, the development of advanced MBs as a multifunctional platform for both imaging and therapy against diseases has shown bright perspectives in various biomedical areas. It can be expected that with the vast and portable application of ultrasound technology, the integration of "bubbles for US" will play a more active role in the future, and will serve the individualized treatments of human diseases in a more precise manner.
